Optison Perflutren Protein-Type A Microspheres .22 mg/mL

Optison Perflutren Protein-Type A Microspheres .22 mg/mL is an injectable solution used for enhancing ultrasound imaging. This product, manufactured by GE Healthcare Inc., contains human albumin microspheres and perflutren, designed for intravenous administration.

Optison Perflutren Protein-Type A Microspheres .22 mg/mL is primarily used as a contrast agent to improve the quality of ultrasound images. It helps in visualizing the heart and blood vessels more clearly, aiding in the diagnosis of various cardiovascular conditions. This product is often utilized in procedures where enhanced imaging is necessary to assess blood flow and heart function.

When administered intravenously, Optison Perflutren Protein-Type A Microspheres .22 mg/mL can enhance the visibility of blood vessels and heart structures during an ultrasound. This improved imaging can help healthcare professionals make more accurate diagnoses. Common effects may include temporary discomfort at the injection site, but these are generally mild and short-lived.

Optison Perflutren Protein-Type A Microspheres .22 mg/mL should be handled with care, ensuring it is used only by trained healthcare professionals. It is important to check for any signs of contamination or damage to the vial before administration. Patients with known allergies to any of the components should avoid using this product.

Optison Perflutren Protein-Type A Microspheres .22 mg/mL may interact with certain medications, particularly those that affect blood flow or heart function. It is advisable to inform healthcare providers about all current medications before using this contrast agent. Additionally, interactions with other contrast agents or imaging dyes should be considered.